BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31079692)

  • 1. Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.
    Paolillo S; Marsico F; Prastaro M; Renga F; Esposito L; De Martino F; Di Napoli P; Esposito I; Ambrosio A; Ianniruberto M; Mennella R; Paolillo R; Gargiulo P
    Heart Fail Clin; 2019 Jul; 15(3):341-347. PubMed ID: 31079692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic cardiomyopathy.
    Lorenzo-Almorós A; Cepeda-Rodrigo JM; Lorenzo Ó
    Rev Clin Esp (Barc); 2022 Feb; 222(2):100-111. PubMed ID: 35115137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    Marwick TH; Ritchie R; Shaw JE; Kaye D
    J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy: ongoing controversies in 2012.
    Seferović PM; Milinković I; Ristić AD; Seferović Mitrović JP; Lalić K; Jotić A; Kanjuh V; Lalić N; Maisch B
    Herz; 2012 Dec; 37(8):880-6. PubMed ID: 23223771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
    Alonso N; Moliner P; Mauricio D
    Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
    Dei Cas A; Spigoni V; Ridolfi V; Metra M
    Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome in heart failure: insights to specific mechanisms.
    Gargiulo P; Marsico F; Renga F; Dell'Aversana S; Esposito I; Marciano C; Dellegrottaglie S; Perrone-Filardi P; Paolillo S
    Heart Fail Rev; 2020 Jan; 25(1):1-7. PubMed ID: 31414215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    Kanamori H; Naruse G; Yoshida A; Minatoguchi S; Watanabe T; Kawaguchi T; Tanaka T; Yamada Y; Takasugi H; Mikami A; Minatoguchi S; Miyazaki T; Okura H
    J Cardiol; 2021 Jan; 77(1):30-40. PubMed ID: 32907780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice.
    Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL
    PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.
    Dandamudi S; Slusser J; Mahoney DW; Redfield MM; Rodeheffer RJ; Chen HH
    J Card Fail; 2014 May; 20(5):304-9. PubMed ID: 24576788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of diabetic cardiomyopathy among type-2 diabetics presenting as heart failure.
    Muhammad Z; Hashmi A
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):538-42. PubMed ID: 23930867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].
    Stratmann B; Worms J; Tschoepe D
    Dtsch Med Wochenschr; 2014 Oct; 139(40):2006-9. PubMed ID: 25254396
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy.
    Kim AH; Jang JE; Han J
    Biomed Pharmacother; 2022 Jan; 145():112463. PubMed ID: 34839258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.